Atea Pharmaceuticals to Host Second Quarter 2025 Financial Results and Business Update Conference Call on August 7, 2025

Core Viewpoint - Atea Pharmaceuticals, Inc. will host a live conference call on August 7, 2025, to report its financial results for Q2 2025 and provide a business update [1]. Company Overview - Atea Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering and developing oral antiviral therapies for serious viral diseases [3]. - The company utilizes a proprietary nucleos(t)ide prodrug platform to develop novel product candidates targeting single-stranded RNA viruses [3]. - Atea's lead program focuses on the combination of bemnifosbuvir, a nucleotide analog polymerase inhibitor, and ruzasvir, an NS5A inhibitor, aimed at treating Hepatitis C Virus (HCV) [3]. Conference Call Details - The conference call will take place at 4:30 p.m. ET on August 7, 2025, and will be accessible via telephone or through an audio webcast on the company's website [2]. - Participants can register for the call and access an archive of the audio webcast approximately two hours after the event, which will remain available for at least 90 days [2].